COVID-19 Infection among Elite Football Players: A Nationwide Prospective Cohort Study.

COVID-19 incidence professional footballers relative risk transmission

Journal

Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355

Informations de publication

Date de publication:
19 Apr 2022
Historique:
received: 14 03 2022
revised: 07 04 2022
accepted: 14 04 2022
entrez: 28 5 2022
pubmed: 29 5 2022
medline: 29 5 2022
Statut: epublish

Résumé

Little is known about the risk of COVID-19 infection among footballers. We aimed to investigate the incidence and characteristics of COVID-19 infection among footballers. In total, 480 football players of Super League Greece and 420 staff members participated in a prospective cohort study, which took place from May 2020 to May 2021. Nasopharyngeal swabs were collected from footballers and staff members weekly. All samples (n = 43,975) collected were tested using the reverse transcriptase polymerase chain reaction (RT-PCR) test for the detection of “SARS-CoV-2”. In total, 190 positive cases (130 among professional football players and 60 among staff) were recorded. Out of the 190 cases that turned positive, 64 (34%) cases were considered as symptomatic, and 126 (66%) cases were asymptomatic. The incidence rate of a positive test result for footballers was 0.57% (confidence interval (CI) 0.48−0.68%) and for staff members it was 0.27% (CI 0.20%, 0.34%), respectively. Footballers recorded a twofold increased risk of COVID-19 infection in comparison to staff members (relative risk = 2.16; 95% CI = 1.59−2.93; p-value < 0.001). No significant transmission events were observed during the follow-up period. We found a low incidence of COVID-19 infection among professional footballers over a long follow-up period. Furthermore, the implementation of a weekly diagnostic testing (RT-PCR) was critical to break the transmission chain of COVID-19, especially among asymptomatic football players and staff members.

Identifiants

pubmed: 35632390
pii: vaccines10050634
doi: 10.3390/vaccines10050634
pmc: PMC9144666
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Acta Biomed. 2016 Sep 13;87(2):117-20
pubmed: 27648991
Br J Sports Med. 2022 Feb;56(3):158-164
pubmed: 34663570
PLoS Med. 2020 Sep 22;17(9):e1003346
pubmed: 32960881
Br J Sports Med. 2021 Oct;55(19):1092-1098
pubmed: 33589470
BMJ. 2011 Aug 08;343:d2090
pubmed: 21824904
Vaccines (Basel). 2021 Oct 21;9(11):
pubmed: 34835152
JAMA Netw Open. 2021 Dec 1;4(12):e2137257
pubmed: 34905008
Occup Med (Lond). 2020 May 27;70(3):200-202
pubmed: 32432327
Sci Med Footb. 2021 Nov;5(sup1):2-7
pubmed: 35077316
Br J Sports Med. 2021 Jul;55(14):807-813
pubmed: 33574043
PLoS One. 2021 Aug 12;16(8):e0254798
pubmed: 34383766
J Sci Med Sport. 2022 Jan;25(1):9-14
pubmed: 34334321
Br Med J (Clin Res Ed). 1988 May 7;296(6632):1313-6
pubmed: 3133061
Br J Sports Med. 2021 Jan;55(1):62-66
pubmed: 32972979
Ann Intern Med. 2020 Sep 1;173(5):362-367
pubmed: 32491919
Scand J Med Sci Sports. 2021 Apr;31(4):936-939
pubmed: 33480037
Int J Environ Res Public Health. 2021 Apr 20;18(8):
pubmed: 33923960
Respir Res. 2020 Aug 27;21(1):224
pubmed: 32854739
Ann Intern Med. 2021 May;174(5):655-662
pubmed: 33481642

Auteurs

Dimitrios Papagiannis (D)

Public Health & Vaccines Lab, Department of Nursing, School of Health Sciences, University of Thessaly Larissa, 411 10 Larissa, Greece.

Theodoros Laios (T)

Super League Greece Mesogeion 174, 151 25 Maroussi, Greece.

Konstantinos Tryposkiadis (K)

Institute of Applied Health Research, University of Birmingham, Birmingham B15 2TT, UK.

Konstantinos Kouriotis (K)

Super League Greece Mesogeion 174, 151 25 Maroussi, Greece.

Xenophon Roussis (X)

Super League Greece Mesogeion 174, 151 25 Maroussi, Greece.

Georgios Basdekis (G)

Super League Greece Mesogeion 174, 151 25 Maroussi, Greece.

Panagiotis Boudouris (P)

Super League Greece Mesogeion 174, 151 25 Maroussi, Greece.

Christos Cholevas (C)

Super League Greece Mesogeion 174, 151 25 Maroussi, Greece.

Stergios Karakitsios (S)

Super League Greece Mesogeion 174, 151 25 Maroussi, Greece.

Pindaros Kakavas (P)

Super League Greece Mesogeion 174, 151 25 Maroussi, Greece.

Theoharis Kiriakidis (T)

Super League Greece Mesogeion 174, 151 25 Maroussi, Greece.

Panagiotis Kouloumentas (P)

Super League Greece Mesogeion 174, 151 25 Maroussi, Greece.

Georgios Kouvidis (G)

Super League Greece Mesogeion 174, 151 25 Maroussi, Greece.

Grigoris Manoudis (G)

Super League Greece Mesogeion 174, 151 25 Maroussi, Greece.

Pantelis Nikolaou (P)

Super League Greece Mesogeion 174, 151 25 Maroussi, Greece.

Christos Theos (C)

Super League Greece Mesogeion 174, 151 25 Maroussi, Greece.

Andreas-Nikolaos Piskopakis (AN)

Super League Greece Mesogeion 174, 151 25 Maroussi, Greece.

Ioannis Rallis (I)

Super League Greece Mesogeion 174, 151 25 Maroussi, Greece.

Stavros Ristanis (S)

Super League Greece Mesogeion 174, 151 25 Maroussi, Greece.

Alexandros Toliopoulos (A)

Super League Greece Mesogeion 174, 151 25 Maroussi, Greece.

Grigoris Zisis (G)

Super League Greece Mesogeion 174, 151 25 Maroussi, Greece.

Yiannis Theodorakis (Y)

Department of Physical Education and Sport Sciences, University of Thessaly, 382 21 Volos, Greece.

Konstantinos I Gourgoulianis (KI)

Department of Respiratory Medicine, School of Health Sciences, University of Thessaly, 411 10 Larissa, Greece.

Georgios Rachiotis (G)

Department of Hygiene and Epidemiology, School of Health Sciences, Faculty of Medicine, University of Thessaly, 411 10 Larissa, Greece.

Classifications MeSH